1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Protein Detection 1.2.3 DNA Detection 1.3 Market by Application 1.3.1 Global Companion Diagnostic Tests in Oncology Market Share by Application: 2020 VS 2026 1.3.2 Pharmaceutical & Biotechnology Companies 1.3.3 Medical Device Companies 1.3.4 Research Institutes 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Companion Diagnostic Tests in Oncology Market Perspective (2015-2026) 2.2 Global Companion Diagnostic Tests in Oncology Growth Trends by Regions 2.2.1 Companion Diagnostic Tests in Oncology Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Companion Diagnostic Tests in Oncology Historic Market Share by Regions (2015-2020) 2.2.3 Companion Diagnostic Tests in Oncology Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Companion Diagnostic Tests in Oncology Players by Market Size 3.1.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue (2015-2020) 3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2015-2020) 3.2 Global Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Companion Diagnostic Tests in Oncology Revenue 3.4 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio 3.4.1 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests in Oncology Revenue in 2019 3.5 Key Players Companion Diagnostic Tests in Oncology Area Served 3.6 Key Players Companion Diagnostic Tests in Oncology Product Solution and Service 3.7 Date of Enter into Companion Diagnostic Tests in Oncology Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Companion Diagnostic Tests in Oncology Breakdown Data by Type (2015-2026) 4.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Type (2015-2020) 4.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2021-2026) 5 Companion Diagnostic Tests in Oncology Breakdown Data by Application (2015-2026) 5.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Application (2015-2020) 5.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Companion Diagnostic Tests in Oncology Market Size (2015-2026) 6.2 North America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) 6.3 North America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) 6.4 North America Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Companion Diagnostic Tests in Oncology Market Size (2015-2026) 7.2 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) 7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) 7.4 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Companion Diagnostic Tests in Oncology Market Size (2015-2026) 8.2 China Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) 8.3 China Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) 8.4 China Companion Diagnostic Tests in Oncology Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Companion Diagnostic Tests in Oncology Market Size (2015-2026) 9.2 Japan Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) 9.3 Japan Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) 9.4 Japan Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Companion Diagnostic Tests in Oncology Market Size (2015-2026) 10.2 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) 10.3 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) 10.4 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Abbott 11.1.1 Abbott Company Details 11.1.2 Abbott Business Overview 11.1.3 Abbott Companion Diagnostic Tests in Oncology Introduction 11.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)) 11.1.5 Abbott Recent Development 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Companion Diagnostic Tests in Oncology Introduction 11.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) 11.2.5 Roche Recent Development 11.3 Genomic Health 11.3.1 Genomic Health Company Details 11.3.2 Genomic Health Business Overview 11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Introduction 11.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) 11.3.5 Genomic Health Recent Development 11.4 QIAGEN 11.4.1 QIAGEN Company Details 11.4.2 QIAGEN Business Overview 11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Introduction 11.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) 11.4.5 QIAGEN Recent Development 11.5 Agilent 11.5.1 Agilent Company Details 11.5.2 Agilent Business Overview 11.5.3 Agilent Companion Diagnostic Tests in Oncology Introduction 11.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) 11.5.5 Agilent Recent Development 11.6 Agendia 11.6.1 Agendia Company Details 11.6.2 Agendia Business Overview 11.6.3 Agendia Companion Diagnostic Tests in Oncology Introduction 11.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) 11.6.5 Agendia Recent Development 11.7 BioMerieux 11.7.1 BioMerieux Company Details 11.7.2 BioMerieux Business Overview 11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Introduction 11.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) 11.7.5 BioMerieux Recent Development 11.8 Illumina 11.8.1 Illumina Company Details 11.8.2 Illumina Business Overview 11.8.3 Illumina Companion Diagnostic Tests in Oncology Introduction 11.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) 11.8.5 Illumina Recent Development 11.9 Siemens Healthcare 11.9.1 Siemens Healthcare Company Details 11.9.2 Siemens Healthcare Business Overview 11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Introduction 11.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) 11.9.5 Siemens Healthcare Recent Development 11.10 Thermo Fisher 11.10.1 Thermo Fisher Company Details 11.10.2 Thermo Fisher Business Overview 11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Introduction 11.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) 11.10.5 Thermo Fisher Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Protein Detection Table 4. Key Players of DNA Detection Table 5. Global Companion Diagnostic Tests in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 6. Global Companion Diagnostic Tests in Oncology Market Size by Regions (US$ Million): 2020 VS 2026 Table 7. Global Companion Diagnostic Tests in Oncology Market Size by Regions (2015-2020) (US$ Million) Table 8. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2015-2020) Table 9. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 10. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2021-2026) Table 11. Companion Diagnostic Tests in Oncology Market Market Trends Table 12. Companion Diagnostic Tests in Oncology Market Drivers Table 13. Companion Diagnostic Tests in Oncology Market Challenges Table 14. Companion Diagnostic Tests in Oncology Market Restraints Table 15. Global Companion Diagnostic Tests in Oncology Revenue by Players (2015-2020) (US$ Million) Table 16. Global Companion Diagnostic Tests in Oncology Market Share by Players (2015-2020) Table 17. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2019) Table 18. Global Companion Diagnostic Tests in Oncology by Players Market Concentration Ratio (CR5 and HHI) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Companion Diagnostic Tests in Oncology Product Solution and Service Table 21. Mergers & Acquisitions, Expansion Plans Table 22. Global Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million) Table 23. Global Companion Diagnostic Tests in Oncology Market Size Share by Type (2015-2020) Table 24. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2021-2026) Table 25. Global Companion Diagnostic Tests in Oncology Market Size Share by Application (2015-2020) Table 26. Global Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million) Table 27. Global Companion Diagnostic Tests in Oncology Market Size Share by Application (2021-2026) Table 28. North America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million) Table 29. North America Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020) Table 30. North America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million) Table 31. North America Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020) Table 32. North America Companion Diagnostic Tests in Oncology Market Size by Country (US$ Million) (2015-2020) Table 33. North America Companion Diagnostic Tests in Oncology Market Share by Country (2015-2020) Table 34. Europe Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million) Table 35. Europe Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020) Table 36. Europe Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million) Table 37. Europe Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020) Table 38. Europe Companion Diagnostic Tests in Oncology Market Size by Country (US$ Million) (2015-2020) Table 39. Europe Companion Diagnostic Tests in Oncology Market Share by Country (2015-2020) Table 40. China Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million) Table 41. China Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020) Table 42. China Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million) Table 43. China Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020) Table 44. China Companion Diagnostic Tests in Oncology Market Size by Region (US$ Million) (2015-2020) Table 45. China Companion Diagnostic Tests in Oncology Market Share by Region (2015-2020) Table 46. Japan Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million) Table 47. Japan Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020) Table 48. Japan Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million) Table 49. Japan Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020) Table 50. Japan Companion Diagnostic Tests in Oncology Market Size by Country (US$ Million) (2015-2020) Table 51. Japan Companion Diagnostic Tests in Oncology Market Share by Country (2015-2020) Table 52. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020) (US$ Million) Table 53. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Type (2015-2020) Table 54. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020) (US$ Million) Table 55. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Application (2015-2020) Table 56. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Country (US$ Million) (2015-2020) Table 57. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Country (2015-2020) Table 58. Abbott Company Details Table 59. Abbott Business Overview Table 60. Abbott Product Table 61. Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million) Table 62. Abbott Recent Development Table 63. Roche Company Details Table 64. Roche Business Overview Table 65. Roche Product Table 66. Roche Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million) Table 67. Roche Recent Development Table 68. Genomic Health Company Details Table 69. Genomic Health Business Overview Table 70. Genomic Health Product Table 71. Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million) Table 72. Genomic Health Recent Development Table 73. QIAGEN Company Details Table 74. QIAGEN Business Overview Table 75. QIAGEN Product Table 76. QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million) Table 77. QIAGEN Recent Development Table 78. Agilent Company Details Table 79. Agilent Business Overview Table 80. Agilent Product Table 81. Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million) Table 82. Agilent Recent Development Table 83. Agendia Company Details Table 84. Agendia Business Overview Table 85. Agendia Product Table 86. Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million) Table 87. Agendia Recent Development Table 88. BioMerieux Company Details Table 89. BioMerieux Business Overview Table 90. BioMerieux Product Table 91. BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million) Table 92. BioMerieux Recent Development Table 93. Illumina Business Overview Table 94. Illumina Product Table 95. Illumina Company Details Table 96. Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million) Table 97. Illumina Recent Development Table 98. Siemens Healthcare Company Details Table 99. Siemens Healthcare Business Overview Table 100. Siemens Healthcare Product Table 101. Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million) Table 102. Siemens Healthcare Recent Development Table 103. Thermo Fisher Company Details Table 104. Thermo Fisher Business Overview Table 105. Thermo Fisher Product Table 106. Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020) (US$ Million) Table 107. Thermo Fisher Recent Development Table 108. Research Programs/Design for This Report Table 109. Key Data Information from Secondary Sources Table 110. Key Data Information from Primary Sources List of Figures Figure 1. Global Companion Diagnostic Tests in Oncology Market Share by Type: 2020 VS 2026 Figure 2. Protein Detection Features Figure 3. DNA Detection Features Figure 4. Global Companion Diagnostic Tests in Oncology Market Share by Application: 2020 VS 2026 Figure 5. Pharmaceutical & Biotechnology Companies Case Studies Figure 6. Medical Device Companies Case Studies Figure 7. Research Institutes Case Studies Figure 8. Companion Diagnostic Tests in Oncology Report Years Considered Figure 9. Global Companion Diagnostic Tests in Oncology Market Size (US$ Million), YoY Growth 2015-2026 Figure 10. Global Companion Diagnostic Tests in Oncology Market Share by Regions: 2020 VS 2026 Figure 11. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2021-2026) Figure 12. Global Companion Diagnostic Tests in Oncology Market Share by Players in 2019 Figure 13. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2019 Figure 14. The Top 10 and 5 Players Market Share by Companion Diagnostic Tests in Oncology Revenue in 2019 Figure 15. North America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 16. United States Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 17. Canada Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. Europe Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Germany Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. France Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. U.K. Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Italy Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Russia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Nordic Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Rest of Europe Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. China Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Japan Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. South Korea Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Southeast Asia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. India Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Australia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Rest of Asia-Pacific Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Latin America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Mexico Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Brazil Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Turkey Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Saudi Arabia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. UAE Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Rest of Middle East & Africa Companion Diagnostic Tests in Oncology Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Abbott Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020) Figure 43. Roche Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020) Figure 44. Genomic Health Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020) Figure 45. QIAGEN Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020) Figure 46. Agilent Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020) Figure 47. Agendia Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020) Figure 48. BioMerieux Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020) Figure 49. Illumina Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020) Figure 50. Siemens Healthcare Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020) Figure 51. Thermo Fisher Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2015-2020) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Abbott Roche Genomic Health QIAGEN Agilent Agendia BioMerieux Illumina Siemens Healthcare Thermo Fisher